|
| |
Image Results
Loading...
Loading...
CASODEX Pages on BioPortfolio:
|
BioPortfolio Limited Prostate Cancer - Hormone-refractory patients ...
Casodex is by far the preferred anti-androgen for use as monotherapy in each of the seven ... Casodex 150mg has had a tumultuous regulatory pathway to date ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_310.html...
|
BioPortfolio.com - BioWeb Mastocytosis Search
... EQ 180MG BASE/5ML SUSPENSION) (CEPHALOSPORIN) 20-498 CASODEX ZENECA BICALUTAMIDE 14-SEP-95 (TABLET) WILMINGTON, DE 50MG 19850 (ANTIANDROGEN) [USE IN
. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
The Cancer Market Outlook to 2009
Casodex 68. Androcur 72. Anti-estrogens 73. Drug analysis 74. Nolvadex 74. Aromatase inhibitors 79 ... Figure 2.7: Casodex: SWOT analysis 72 ...
http://www.bioportfolio.com/news/datamonitor_92.htm...
|
BioPortfolio.com - BioWeb CEDAX CEFTIBUTEN DIHYDRATE Search
... NJ EQ 90MG BASE/5ML FOR ORAL 07033 EQ 180MG BASE/5ML SUSPENSION) ( CEPHALOSPORIN) 20-498 CASODEX ZENECA BICALUTAMIDE 14-SEP-95 (TABLET) WILMINGTON,
. ...
http://www.bioportfolio.co.uk/CEDAX+CEFTIBUTEN+DIHYDRATE-bio...
|
The World Market for Cancer Therapeutics and Biotherapeutics, 3rd ...
AstraZeneca (coverage of Arimidex, Casodex, Faslodex, Zoladex, Iressa, Nolvadex and other products). * Biogen IDEC (coverage of Rituxan and other products) ...
http://www.bioportfolio.com/cgi-bin/acatalog/The_World_Marke...
|
BioPortfolio Limited Commercial Insight: Antihormonal Therapy ...
Table 56: Casodex: brand forecast events 139. Table 57: Casodex forecast sales in the seven major markets ($m), 2007-2017 140 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_499.html...
|
BioPortfolio Limited Oncology Market Leaders - Analyses and ...
Table 3.19 Global Sales of Casodex, 2004-2007. Table 3.20 Casodex Market Sales Forecast, 2008-2023 .... Figure 3.20 Casodex Market Sales Forecast, 2008-2023
...
http://www.bioportfolio.com/cgi-bin/acatalog/info_468.html...
| Results from other life science and pharmaceutical sites:
Bicalutamide - Wikipedia, the free encyclopedia
Bicalutamide (marketed as Casodex, Cosudex, Calutide, Kalumid) is an ... Bicalutamide is marketed by AstraZeneca with the brand names Casodex and Cosudex
. ...
http://en.wikipedia.org/wiki/Bicalutamide...
|
Casodex, cosudex, (bicalutamide) - anti androgen, prostate cancer ...
Casodex, Cosudex (bicalutamide) information, an anti androgen for prostate cancer provided by AstraZeneca.
http://www.astrazeneca.com/medicines/?itemId=3888008...
|
Bicalutamide: MedlinePlus Drug Information
Casodex®. Last Reviewed - 09/01/2008. ASHP Logo American Society of Health- System Pharmacists, Inc. Disclaimer. AHFS® Consumer Medication Information. ...
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a697047.htm...
|
casodex (Bicalutamide) tablet [AstraZeneca Pharnaceuticals LP ...
CASODEX® (bicalutamide) Tablets for oral administration contain 50 mg of bicalutamide, a non-steroidal antiandrogen with no other known endocrine
activity. ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=4740...
|
The pharmacokinetics of Casodex enantiomers in subjects with ...
Casodex is a novel non-steroidal antiandrogen being developed for the treatment of prostatic cancer. The antiandrogenic activity is predominantly in the ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1364687/...
|
Kapidex-Casodex confusion
There have been reported instances of medication errors due to name confusion between KAPIDEX (dexlansoprazole) and CASODEX (bicalutamide). ...
http://www.ismp.org/newsletters/acutecare/articles/20090813-...
|
Casodex treatment induces hypoxia-related gene expression in the ...
We examined the gene expression profile in the LNCaP prostate cancer progression model during chronic treatment with Casodex using cDNA microarrays ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079894/...
|
Prostate Cancer and Prostatic Diseases - Bicalutamide (/`Casodex ...
Bicalutamide ('Casodex') 150 mg in addition to standard care in patients with nonmetastatic prostate cancer: updated results from a randomised double-blind
...
http://www.nature.com/pcan/journal/v8/n2/full/4500799a.html...
|
Health and Drug Alerts: Safety updates: repaglinide (GlucoNorm ...
(Health Canada has not approved Casodex 150 mg for the treatment of locally advanced disease ... Important drug safety information: Casodex 150 mg [letter].
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC203288/...
|
Casodex (bicalutamide) Tablets February 2009
11 Jul 2009 ... Casodex (bicalutamide) Tablets February 2009. Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...
|
|
